期刊文献+

冠状动脉搭桥术-体外循环患者炎性指标和心肌损伤标志物的检测分析 被引量:1

Analysis of Inflammatory Factors and Myocardial Damage Markers by Testing the Patients Undergone CABG Surgery by CPB
下载PDF
导出
摘要 目的:检测分析冠状动脉搭桥术(CABG)-体外循环(CPB)冠心病(CHD)患者的炎性和心肌损伤监测指标。方法:分别在CPB前、中、后即刻、后2h、6h、12h、24h、48h,测定炎性指标白介素-6(IL-6)、白介素-8(IL-8)、白细胞数量(WBC)及心肌损伤标志物肌红蛋白(MYO)、肌钙蛋白I(cTnI)、肌酸激酶同工酶MB质量(CK-MBmass),并对WBC和cTnI变化进行趋势分析。结果:IL-6和IL-8在CPB后逐渐上升;WBC和cTnI在CPB后开始逐渐上升,CPB后24h达到高峰,然后下降;WBC和cTnI与其它指标呈明显正相关(P<0.01);MYO在CPB后即刻和CPB后24h出现双峰。结论:行CABG-CPB患者炎症和心肌损伤指标的监测有重要临床意义。 Objective: To analyze and optimize the monitoring items of inflammatory reaction and myocardial damage for the patients with coronary heart disease (CHD), who will be undergone coronary artery by pass graft (CABG) surgery by cardiopulmonary bypass (CPB). Method: Interleukin-6 (IL-6), interleukin-8 (IL-8), white blood cell (WBC), myoglobulin (MYO), troponin I (cTnI), creatine kinase MB mass (CK-MB mass) were tested in different time spots which in order are before CPB, on CPB, after CPB at that time, after CPB 2 hour, after CPB 6 hour, after CPB 12 hour, after CPB 24 hour, after CPB 48 hour. Then analyze the changing tendencies of the preferential monitoring items WBC and cTnI. Results: The values of IL-6 and IL-8 ascend gradually after CPB.The values of WBC and cTnI begin to ascend after CPB at that time, achieve the peak after CPB 24 hour, then descend. They have distinct positive correlations (P<0.01) with other examination items. Moreover their dynamic state curves are easy to be observed. The value of MYO achieves the peak twice after CPB at that time and after CPB 24 hour. Conclusion: WBC and cTnI are the preferential monitoring items of inflammatory reaction and myocardial damage for the patients undergone CABG surgery by CPB.
出处 《微循环学杂志》 2007年第4期53-55,共3页 Chinese Journal of Microcirculation
关键词 心肌损伤标志物 冠状动脉搭桥术 体外循环 检测分析 炎性指标 肌酸激酶同工酶MB 器官功能障碍 细胞因子 Inflammatory reaction Myocardial damage marker Coronary artery by pass graft cardiopulmonary bypass
  • 相关文献

参考文献9

  • 1Seghaye MC, Grabitz RG, Duchateau J, et al. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary by-pass in neonates undergoing cardiac operations. J Thorac CardiovascSurg,1996,112(6):687-697.
  • 2Hirai S. Systemic inflammatory response syndrome after cardiac-surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg,2003,9(6):365-370.
  • 3李艳 ,黄从新 .重要炎性因子在冠心病病理过程中的作用[J].微循环学杂志,2004,14(1):47-49. 被引量:16
  • 4Fletcher MP, Stahl G, Longhurst J. C5a-induced myocardial is-c hemia. Am J Physiol 265 (Heart Circ Physiol), 1993,34(8):1750-1761.
  • 5Kunkel SL, Standiford T, Kasahara K, et al. erleukin-8 (IL-8):the major neutrophil chemotactic factor in the lung. Exp Lung Res,1991,17(1):17-23.
  • 6Venge P,Lagerqvist B,Diderholm E, et al. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease(a FRISC II substudy). Am J Cardla,2002,89(4):1035-1041.
  • 7Christenson RH,Azzazy HM. Biochemical markers of the acute coronary syndromes. Clin Chem, 1998,44(8):1855.
  • 8宋斌斌,郭玮,潘柏申.心肌标志物在心脏手术后的应用价值[J].上海医学检验杂志,2003,18(1):15-17. 被引量:6
  • 9邵丽丽,刘萍,王明荣.体外循环心脏术后心肌损伤标志物的变化[J].重庆医学,2006,35(18):1645-1646. 被引量:13

二级参考文献27

  • 1[1]Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340:115~126.
  • 2[2]Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J AM Coll Cardiol, 1998, 31:1 217~1 225.
  • 3[3]Schreyer SA, Vick CM,LeBoeuf RC. Loss of lymphotoxin-α but not tumor necrosis factor-α reduces atherosclerosis in mice. J Biol Chem, 2002, 277:12 364~12 368.
  • 4[4]Libby P, Warner SJ, Friedman GB. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest,1998, 81:487~498.
  • 5[5]Kastrati A, Koch W, Berger PB, et al. Protective role against restenosis from an interleukin-1receptor antagonist gene polymorphism in patients treated with coronary stenting. JACC, 2000, 36:2 168~2 173.
  • 6[6]Dewberry R, Holden H, Crossman D, et al. Interleukin-1 receptor antagonist expression in human endothelial cell and atherosclerosis. Arterioscler Thromb Vasc Biol, 2000, 20:2 394~2 400.
  • 7[7]Galea J, Armstrong JA, Gadsdon PA, et al. Interleukin-1β in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol, 1996, 16:1 000~1 006.
  • 8[8]Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects-associations with obesity, insulin resistance and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Art Thromb Vasc Biol,1999,19:972~978.
  • 9[9]Romano M, Sironi M, Toniatti C, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity,1997,6:1–20.
  • 10[10]Davies MJ. The composition of coronary artery plaques. New Engl J med, 1997, 336:1 312~1 314.

共引文献32

同被引文献1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部